Drug-drug Interaction Study With GLPG3970 and Sulfasalazine in Adult, Healthy Subjects
Status:
Completed
Trial end date:
2021-04-23
Target enrollment:
Participant gender:
Summary
GLPG3970 will be given with sulfasalazine to investigate the effect of co-administration on
the pharmacokinetics of sulfasalazine, and on the safety and tolerability of the drugs in
healthy adult subjects.